COVID-19 vaccine efficacy data: solid enough to delay second dose?

por Robertson, John F R, Sewell, Herb F
Publicado 2021

Delayed second dose of the BNT162b2 vaccine: innovation or misguided conjecture?

por Robertson, John F R, Sewell, Herb F, Stewart, Marcia
Publicado 2021

Arzoxifene: the evidence for its development in the management of breast cancer

por Jackson, Lee R., Cheung, Kwok L., Buzdar, Aman U., Robertson, John F. R.
Publicado 2007

Improving primary care identification of familial breast cancer risk using proactive invitation and decision support

por Qureshi, Nadeem, Dutton, Brittany, Weng, Stephen, Sheehan, Christina, Chorley, Wendy, Robertson, John F. R., Kendrick, Denise, Kai, Joe
Publicado 2020

erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines

por Knowlden, Janice M, Gee, Julia MW, Barrow, Denise, Robertson, John F, Ellis, Ian O, Nicholson, Robert I, Hutcheson, Iain R
Publicado 2011

Determinants of motivation to quit in smokers screened for the early detection of lung cancer: a qualitative study

por Young, Ben, Vedhara, Kavita, Kendrick, Denise, Littleford, Roberta, Robertson, John F. R., Sullivan, Frank M., Schembri, Stuart, das Nair, Roshan
Publicado 2018

A meta-analysis of clinical benefit rates for fulvestrant 500 mg vs. alternative endocrine therapies for hormone receptor-positive advanced breast cancer

por Robertson, John F. R., Jiang, Zefei, Di Leo, Angelo, Ohno, Shinji, Pritchard, Kathleen I., Ellis, Matthew, Bradbury, Ian, Campbell, Christine
Publicado 2019

Fulvestrant 500 mg Versus Anastrozole 1 mg for the First-Line Treatment of Advanced Breast Cancer: Overall Survival Analysis From the Phase II FIRST Study

por Ellis, Matthew J., Llombart-Cussac, Antonio, Feltl, David, Dewar, John A., Jasiówka, Marek, Hewson, Nicola, Rukazenkov, Yuri, Robertson, John F.R.
Publicado 2015

Biological effects of fulvestrant on estrogen receptor positive human breast cancer: short, medium and long‐term effects based on sequential biopsies

por Agrawal, Amit, Robertson, John F.R., Cheung, Kwok L., Gutteridge, Eleanor, Ellis, Ian O., Nicholson, Robert I., Gee, Julia M.W.
Publicado 2015

Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells

por Hutcheson, Iain R, Knowlden, Janice M, Hiscox, Steve E, Barrow, Denise, Gee, Julia MW, Robertson, John F, Ellis, Ian O, Nicholson, Robert I
Publicado 2007

Meta-analyses of visceral versus non-visceral metastatic hormone receptor-positive breast cancer treated by endocrine monotherapies

por Robertson, John F. R., Di Leo, Angelo, Johnston, Stephen, Chia, Stephen, Bliss, Judith M., Paridaens, Robert J., Lichfield, Jasmine, Bradbury, Ian, Campbell, Christine
Publicado 2021

Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care

por Garreffa, Emanuele, Hamad, Ahmed, O'Sullivan, Ciara C., Hazim, Antonious Z., York, Joanne, Puri, Shama, Turnbull, Anne, Robertson, John F., Goetz, Matthew P.
Publicado 2021

Development and Validation of a High Throughput System for Discovery of Antigens for Autoantibody Detection

por Macdonald, Isabel K., Allen, Jared, Murray, Andrea, Parsy-Kowalska, Celine B., Healey, Graham F., Chapman, Caroline J., Sewell, Herbert F., Robertson, John F. R.
Publicado 2012

Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells

por Hutcheson, Iain R., Knowlden, Janice M., Hiscox, Steve E., Barrow, Denise, Gee, Julia M. W., Robertson, John F., Ellis, Ian O., Nicholson, Robert I.
Publicado 2018

Application of a High Throughput Method of Biomarker Discovery to Improvement of the EarlyCDT(®)-Lung Test

por Macdonald, Isabel K., Murray, Andrea, Healey, Graham F., Parsy-Kowalska, Celine B., Allen, Jared, McElveen, Jane, Robertson, Chris, Sewell, Herbert F., Chapman, Caroline J., Robertson, John F. R.
Publicado 2012

The clinical significance of oestrogen receptor expression in breast ductal carcinoma in situ

por Miligy, Islam M., Toss, Michael S., Shiino, Sho, Oni, Georgette, Syed, Binafsha M., Khout, Hazem, Tan, Qing Ting, Green, Andrew R., Macmillan, R. Douglas, Robertson, John F. R., Rakha, Emad A.
Publicado 2020

Correction: The clinical significance of oestrogen receptor expression in breast ductal carcinoma in situ

por Miligy, Islam M., Toss, Michael S., Shiino, Sho, Oni, Georgette, Syed, Binafsha M., Khout, Hazem, Tan, Qing Ting, Green, Andrew R., Macmillan, R. Douglas, Robertson, John F. R., Rakha, Emad A.
Publicado 2020

Human Blood Autoantibodies in the Detection of Colorectal Cancer

por Negm, Ola H., Hamed, Mohamed R., Schoen, Robert E., Whelan, Richard L., Steele, Robert J., Scholefield, John, Dilnot, Elizabeth M., Shantha Kumara, H. M. C., Robertson, John F. R., Sewell, Herbert F.
Publicado 2016

Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers

por Bergamino, Milana A., Morani, Gabriele, Parker, Joel, Schuster, Eugene F., Leal, Mariana F., López-Knowles, Elena, Tovey, Holly, Bliss, Judith M., Robertson, John F.R., Smith, Ian E., Dowsett, Mitch, Cheang, Maggie C.U.
Publicado 2022

Serum Autoantibody Measurement for the Detection of Hepatocellular Carcinoma

por Middleton, Catrin H., Irving, William, Robertson, John F. R., Murray, Andrea, Parsy-Kowalska, Celine B., Macdonald, Isabel K., McElveen, Jane, Allen, Jared, Healey, Graham F., Thomson, Brian J., Ryder, Stephen J., Holdenrieder, Stefan, Chapman, Caroline J.
Publicado 2014